Summary
athenahealth's More Disruption Please (MDP) will feature a select group of 75 CEOs from innovative, high potential Health IT companies to explore how ways to collaborate push the boundaries of healthcare and make it work as it should. Goodwin is a sponsor of this annual event.
Related Content
- Big Molecule WatchMarch 15, 2024
Fresenius Kabi Announces FDA Approval of TYENNE, a Tocilizumab Biosimilar Referencing ACTEMRA
- AlertMarch 15, 2024
In Continuing Efforts to Incentivize Self-Disclosures and Cooperation, DOJ Announces Pilot Program to Pay Criminal Whistleblowers
- Life Sciences PerspectivesMarch 14, 2024
FDA’s Laboratory Developed Test (LDT) Final Rule Under OIRA Review; Subcommittee on Health to Hold Hearing on Regulation of Diagnostic Tests
- Life Sciences PerspectivesMarch 13, 2024
Major Life Sciences Licensing Deal Trends in China in 2023
- Life Sciences PerspectivesMarch 13, 2024
USPTO’s New Guidance on AI-Assisted Inventions: The Impact on the Use of AI in the Life Sciences
- InsightMarch 13, 2024
Major Life Sciences Licensing Deal Trends in China in 2023
- Big Molecule WatchMarch 8, 2024
FDA Approves Sandoz Denosumab Biosimilars
- Big Molecule WatchMarch 7, 2024
Biocon Settles with Bayer and Regeneron, Securing Canada Market Entry Date for Aflibercept Biosimilar
- WebinarMarch 27, 2024
Updates on the Drug Price Negotiation Program of the Inflation Reduction Act: An Overview of Recent Court Decisions, the Status of Remaining Challenges, and the Status of “Negotiations”
- Speaking EngagementsMarch 17, 2024
ACS Spring 2024: Many Flavors of Chemistry
- Awards and RankingsMarch 14, 2024
Chambers Europe 2024 Recognizes Goodwin Across Germany, France, and the United Kingdom
- EventsMarch 13, 2024 | 12:00 PM - 5:15 PM ET
Goodwin’s Annual Rare Disease Symposium 2024
- Speaking EngagementsMarch 13, 2024
ACI's 42nd FDA Boot Camp
- Awards and RankingsMarch 8, 2024
Women, Influence & Power in Law UK Awards Recognize Sophie McGrath for Collaborative Leadership
- In the PressMarch 8, 2024
Cambrian Robotics Closes $3.5 million Seed+ Funding Round
- Press ReleaseMarch 7, 2024
Sionna Therapeutics Completes $182 Million Series C